What is Data Spectrum Corporation?
Founded in 1981, Data Spectrum Corporation specializes in the creation of advanced molecular imaging phantoms. These essential tools are utilized by medical imaging professionals for rigorous acceptance testing, consistent quality control, and innovative research purposes. The company's product suite, including SPECT and PET phantoms, is engineered to facilitate the accurate evaluation of imaging equipment, ensuring diagnostic precision and reliability. Data Spectrum's commitment to quality is recognized by the American College of Radiology for accreditation, and its products are proudly manufactured in the USA, reflecting over four decades of expertise and leadership in the field.
How much funding has Data Spectrum Corporation raised?
Data Spectrum Corporation has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Data Spectrum Corporation
PPP
Public-Private Partnership
What's next for Data Spectrum Corporation?
With a substantial total funding amount of $150K and a recent strategic investment of $150K, Data Spectrum Corporation is well-positioned for continued growth and innovation. This backing, particularly in the context of large-scale late-stage funding, suggests a focus on scaling operations, expanding market reach, and potentially developing next-generation imaging solutions. The company's established reputation and specialized product offerings in a critical healthcare niche provide a strong foundation for future strategic initiatives and market leadership.
See full Data Spectrum Corporation company page
